Copper peptide

GHK-Cu

GHK-Cu is discussed in skincare, cosmetic, and broader peptide contexts. This page separates cosmetic discussion from medical or systemic claims.

Evidence review Last reviewed 2026-06-30 Next review 2026-07-30

Evidence snapshot

Use precise language around topical/cosmetic context and require sources for any health claim.

Appears in consumer skincare and peptide content.

Claims vary widely by product category and route of use.

Useful as a lower-risk example of how the site separates contexts.

Tracked claims

GHK-Cu content should distinguish cosmetic topical discussion from broader systemic claims.

Evidence level: Editorial classification

Sources: U.S. Food and Drug Administration

Use the source record to keep the page focused on classification and claim hygiene.

Sources on this page

Source records are stored in the repo and linked from each claim.

Warning Letter: Gram Peptides

U.S. Food and Drug Administration · Primary regulatory · 2026-03-31 · accessed 2026-06-30

FDA warning letter discussing peptide products marketed online and the limits of research-use-only positioning.